Ocugen Statistics
Total Valuation
Ocugen has a market cap or net worth of $233.47 million. The enterprise value is $207.45 million.
Important Dates
The last earnings date was Wednesday, March 5, 2025, before market open.
Earnings Date | Mar 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Ocugen has 292.01 million shares outstanding. The number of shares has increased by 10.92% in one year.
Current Share Class | 292.01M |
Shares Outstanding | 292.01M |
Shares Change (YoY) | +10.92% |
Shares Change (QoQ) | +4.58% |
Owned by Insiders (%) | 1.59% |
Owned by Institutions (%) | 24.61% |
Float | 287.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 53.43 |
Forward PS | n/a |
PB Ratio | 7.86 |
P/TBV Ratio | 7.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 51.16 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 1.10.
Current Ratio | 2.86 |
Quick Ratio | 2.71 |
Debt / Equity | 1.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -154.01% and return on invested capital (ROIC) is -62.43%.
Return on Equity (ROE) | -154.01% |
Return on Assets (ROA) | -46.57% |
Return on Invested Capital (ROIC) | -62.43% |
Return on Capital Employed (ROCE) | -89.98% |
Revenue Per Employee | $42,684 |
Profits Per Employee | -$568,989 |
Employee Count | 95 |
Asset Turnover | 0.06 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.08% in the last 52 weeks. The beta is 3.89, so Ocugen's price volatility has been higher than the market average.
Beta (5Y) | 3.89 |
52-Week Price Change | -55.08% |
50-Day Moving Average | 0.67 |
200-Day Moving Average | 1.03 |
Relative Strength Index (RSI) | 67.42 |
Average Volume (20 Days) | 4,224,438 |
Short Selling Information
The latest short interest is 60.26 million, so 20.64% of the outstanding shares have been sold short.
Short Interest | 60.26M |
Short Previous Month | 58.88M |
Short % of Shares Out | 20.64% |
Short % of Float | 20.97% |
Short Ratio (days to cover) | 17.70 |
Income Statement
In the last 12 months, Ocugen had revenue of $4.05 million and -$54.05 million in losses. Loss per share was -$0.20.
Revenue | 4.05M |
Gross Profit | -28.07M |
Operating Income | -54.76M |
Pretax Income | -50.86M |
Net Income | -54.05M |
EBITDA | -52.79M |
EBIT | -54.76M |
Loss Per Share | -$0.20 |
Full Income Statement Balance Sheet
The company has $58.51 million in cash and $32.50 million in debt, giving a net cash position of $26.01 million or $0.09 per share.
Cash & Cash Equivalents | 58.51M |
Total Debt | 32.50M |
Net Cash | 26.01M |
Net Cash Per Share | $0.09 |
Equity (Book Value) | 29.63M |
Book Value Per Share | 0.10 |
Working Capital | 40.09M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$42.14 million and capital expenditures -$3.39 million, giving a free cash flow of -$45.53 million.
Operating Cash Flow | -42.14M |
Capital Expenditures | -3.39M |
Free Cash Flow | -45.53M |
FCF Per Share | -$0.16 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,350.36% |
Pretax Margin | -1,333.02% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Ocugen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -10.92% |
Shareholder Yield | -10.92% |
Earnings Yield | -23.15% |
FCF Yield | -19.50% |
Analyst Forecast
The average price target for Ocugen is $6.33, which is 691.75% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.33 |
Price Target Difference | 691.75% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 185.99% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ocugen has an Altman Z-Score of -3.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.75 |
Piotroski F-Score | 2 |